Evidence map›Paper›PMID 38996017›Full record

ArticleScience advances2024

Long-lived enhanced magnetization-A practical metabolic MRI contrast material.

Itai Katz, Asher Schmidt, Ira Ben-Shir, Marcia Javitt, Karel Kouřil, Andrea Capozzi, Benno Meier, Arad Lang, Boaz Pokroy, Aharon Blank

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Itai KatzSchulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa 3200003, Israel.ORCID 0009-0005-0549-2395
Asher SchmidtSchulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa 3200003, Israel.
Ira Ben-ShirSchulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa 3200003, Israel.ORCID 0009-0007-9197-9304
Marcia JavittRambam Medical Center, Haifa, Israel.
Karel KouřilInstitute of Biological Interfaces 4, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen 76344, Germany.ORCID 0000-0003-4884-1637
Andrea CapozziLIFMET, Institute of Physics, École Polytechnique Fédérale de Lausanne (EPFL), Station 6, 1015 Lausanne, Switzerland.ORCID 0000-0002-2306-9049
Benno MeierInstitute of Biological Interfaces 4, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen 76344, Germany.ORCID 0000-0003-2258-1507
Arad LangDepartment of Materials Science and Engineering, Technion-Israel Institute of Technology, Haifa 3200003, Israel.ORCID 0000-0003-3692-7628
Boaz PokroyDepartment of Materials Science and Engineering, Technion-Israel Institute of Technology, Haifa 3200003, Israel.
Aharon BlankSchulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa 3200003, Israel.ORCID 0000-0003-4056-8103

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Noninvasive tracking of biochemical processes in the body is paramount in diagnostic medicine. Among the leading techniques is spectroscopic magnetic resonance imaging (MRI), which tracks metabolites with an amplified (hyperpolarized) magnetization signal injected into the subject just before scanning. Traditionally, the brief enhanced magnetization period of these agents limited clinical imaging. We propose a solution based on amalgamating two materials-one having diagnostic-metabolic activity and the other characterized by robust magnetization retention. This combination slows the magnetization decay in the diagnostic metabolic probe, which receives continuously replenished magnetization from the companion material. Thus, it extends the magnetization lifetime in some of our measurements to beyond 4 min, with net magnetization enhanced by more than four orders of magnitude. This could allow the metabolic probes to remain magnetized from injection until they reach the targeted organ, improving tissue signatures in clinical imaging. Upon validation, this metabolic MRI technique promises wide-ranging clinical applications, including diagnostic imaging, therapeutic monitoring, and posttreatment surveillance.

Indexed as

Contrast MediaMagnetic Resonance ImagingAnimalsHumansMagneticsContrast Media

Identifiers

PMID38996017
PMCPMC11244432

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.